Mckesson (MCK) Capital Expenditures Growth (3y) (2012 - 2026)
Mckesson (MCK) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 40.32% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 17.21% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 10.23% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -6.92% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | - |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 98.31% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | - |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -24.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.32% |
| Dec 31, 2025 | -30.55% |
| Sep 30, 2025 | 157.13% |
| Jun 30, 2025 | 3.18% |
| Mar 31, 2025 | 153.03% |
| Dec 31, 2024 | -41.83% |
| Sep 30, 2024 | 88.56% |
| Jun 30, 2024 | -2.59% |
| Mar 31, 2024 | -19.97% |
| Dec 31, 2023 | -18.68% |
| Sep 30, 2023 | -20.43% |
| Jun 30, 2023 | 0.74% |
| Mar 31, 2023 | 0.34% |
| Dec 31, 2022 | 19.91% |
| Sep 30, 2022 | -27.22% |
| Jun 30, 2022 | 43.55% |
| Mar 31, 2022 | -44.50% |
| Dec 31, 2021 | -47.80% |
| Sep 30, 2021 | 42.13% |
| Jun 30, 2021 | -13.22% |